INVESTOR PRESENTATION
MARKET OPPORTUNITY
U.S. Market | CBD
The addition of Heliox to normal daily CBD usage will not significantly impact costs associated with normal regular usage. CBD is non-toxic even in relatively large doses and is typically not associated with any serious or long-term side effects
While CBD can be delivered in numerous ways, inhalation is considered the most effective method and is preferred by many users as the lungs offer a large surface for rapid absorption with immediate effect
16,000,000,000
CBD industry projected market size in the U.S. by 2025
14%
Percentage of Americans use CBD for anxiety, depression, arthritis, insomnia, as well as other indications
U.S. Market | Lung Disease
Pure Scientific Technologies plans to engage key research hospital sites in the U.S. for further development and testing of its products. The current COVID-19 pandemic has put treatment of pulmonary conditions in the forefront of medical priorities.
Our approach of high drug delivery to the target site rather than systemic delivery holds great opportunity as the respiratory system has a large surface area with high bio-availability and the capacity to absorb large quantities of drug making it an optimal delivery.
Investor Relations Contact
Investors interested in learning more about Pure Scientific Technologies Inc. should contact:
L. Michael Cutrer
CEO, President & Director
Tel: 949-253-4650
Email: [email protected]